Industry Reports Services Press Release
  •   Blogs
  • Contact us About us

    North America Breast Cancer Therapeutics Market Forecast 2028 By Therapy (Targeted Therapy, Hormonal Therapy, Chemotherapy, Immunotherapy), Research Report, Country Outlook (U.S., Canada), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share
    Published Date: February 2022   |   Report ID: GR2073   |   Delivery: PDF  Request Free Sample

    North America Breast Cancer Therapeutics Market size surpassed USD 9.9 billion in 2021 and is anticipated to exhibit around 7.4% CAGR from 2022 to 2028.

    The increasing prevalence of breast cancer in the region is expected to proliferate the North America market growth significantly. According to the Breast Cancer.org 2021 statistics, breast cancer is amongst the most prevalent form of cancer among American women. The estimates suggest that in 2022, approximately 30% of newly diagnosed cancers among women are expected to be breast cancer cases. As of January 2022, over 3.8 million women in the U.S. are suffering from breast cancer. Also, around 1 in 8 women (around 13%) in the U.S. are expected to be diagnosed with invasive breast cancer over the course of their lifetime. The surging prevalence and substantial incidence rates of the disease are anticipated to promote the demand for breast cancer therapeutics. Further, the disease inflicts substantial disease and financial burden on the healthcare systems.

    North America Breast Cancer Therapeutics Market

    Get more details on this report - Request Free Sample PDF

    The increasing awareness regarding breast cancer owing to supportive initiatives launched in the region will encourage the patients to undergo therapeutics. For instance, the Center for Disease Control and Prevention (CDC) collaborates with public, private, and non-profit organizations to educate people regarding breast cancer through a variety of activities. The Our Bring Your Brave program offers knowledge concerning breast cancer to women. Further, the Advisory Committee on Breast Cancer in Young Women, provides guidance concerning advancement, implementation, and assessment of evidence-sourced activities targeting prevention, early detection, and survivorship of breast cancer. The Cancer Genomics Program innovates optimal practices in education, surveillance, and reinstates an evidence base for the utilization of cancer genomics in public health practice.

    North America Market, By Therapy

    The targeted therapy segment will showcase 7.8% growth rate during the forecast period. Breast cancer targeted therapies employ medications that inhibit the growth of cancerous cells by interfering with the tumor cell proliferation. Owing to the recent advancements in molecular biology and immunotherapy, very precise targeted therapies have been developed to target the specific pathophysiology of breast cancer. These ongoing advancements have contributed to develop a more target specific and efficient therapeutic protocol in breast cancer patients.

    Several targeted therapies are commercially available for application in cancer treatment such as gene expression modulators, signal transduction inhibitors, angiogenesis inhibitors, apoptosis inducers, and toxin delivery molecules. These therapies are currently emphasized for anticancer drug development and are being increasingly used in precision medicine.

    North America Market, By Country

    U.S. breast cancer therapeutics market accounted over USD 9.3 billion revenue in 2021. This large market size is attributed to the rising prevalence of breast cancer, incremental cancer care expenditure, and facilitative reimbursement scenario in the country. etc.

    As per the U.S. Breast Cancer Statistics 2022, an estimated 287,850 new cases of invasive breast cancer are projected to be detected among the U.S. women, along with 51,400 new cases of non-invasive (in situ) breast cancer. Further, approximately 43,250 women are estimated to die in 2022 pertaining to breast cancer. Owing to such high prevalence rates, the government expenditure concerning cancer care is rising.

    Competitive Industry Landscape

    Prominent industry participants operating across the North America include AstraZeneca, Eli Lilly, & Co., Pfizer, BMS, Novartis, Amgen, Roche, and Merck. These major companies are adopting various organic and inorganic strategies such as product launches and partnerships for garnering maximum market share and strengthening their presence.

    Frequently Asked Question(FAQ) :

    How large is the breast cancer therapeutics market?
    The market share for breast cancer therapeutics in North America was exceeded USD 9.9 billion in 2021 and is expected to grow at a CAGR of 7.4% between 2022 and 2028 owing to the surging prevalence of breast cancer in the region.
    What factors will drive North America breast cancer therapeutics industry value from targeted therapies?
    The market revenue from targeted therapies is estimated to depict a growth rate of 7.8% through 2028 driven by the recent advancements in immunotherapy and molecular biology.
    Why is the breast cancer therapeutics sector growing in the U.S.?
    The market size for breast cancer therapeutics in U.S. was surpassed USD 9.3 billion in 2021 and is anticipated to exhibit lucrative growth up to 2028 considering the incremental cancer care expenditure.
    Which are leading players in the North America breast cancer therapeutics landscape?
    Major participants in the North America industry comprise Amgen, AstraZeneca, Merck, Eli Lilly & Co., Roche, BMS, Novartis, Pfizer, and others.

    Get this research report on North America Breast Cancer Therapeutics Market customized according to your business requirements.

    report-purchase - logo Buy Now

    Why Choose us?

    • on-time delivery On-Time Delivery

      We commit to on-time delivery of reports to keep you ahead.

    • assured quality Assured Quility

      With a wide network of industry experts and trained in-house analysts, we assure best service quality.

    • Custom Research Service

      We offer research services to meet specific client requirements and provide them with actionable insights on target markets.

    • payment security Payment Security

      Our safe payment gateway gives you full control of your personal data, at all times.

    Connect with our sales team


     [email protected]